selected publications
-
Journal Article
- Long-term blood pressure variability and kidney function in participants of the ASPREE Trial. American Journal of Hypertension. 2022
- Minnesota Electronic Health Record Consortium COVID-19 Project: informing pandemic response through statewide collaboration using observational data. Public Health Reports. 2022
- Long-term blood pressure variability and risk of cognitive decline and dementia among older adults. Journal of the American Heart Association. 2021
- Antihypertensive medication use and blood pressure control among treated older adults. Journal of Clinical Hypertension (Greenwich, Conn.). 2020
- Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study. American Journal of Hypertension. 2020
- Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individuals. Journal of Hypertension. 2020
- Effect of aspirin on all-cause mortality in the healthy elderly. New England Journal of Medicine. 2018
- Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. New England Journal of Medicine. 2018
- Effect of aspirin on disability-free survival in the healthy elderly. New England Journal of Medicine. 2018
- Prevalence and risk of severe cognitive impairment in advanced chronic kidney disease. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 2018
- Serum phosphate and cognitive function in older men. International Journal of Geriatric Psychiatry. 2018
- Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 2017
- The Brain in Kidney Disease (BRINK) Cohort Study: design and baseline cognitive function. American Journal of Kidney Diseases. 2016
- Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA internal medicine. 2014
- Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurology. 2011